Drug Type Small molecule drug |
Synonyms Emperacin, エンペラシン |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Japan (15 Mar 1994), |
Regulation- |
Molecular FormulaC20H23ClN2O4 |
InChIKeyDBAKFASWICGISY-BTJKTKAUSA-N |
CAS Registry113-92-8 |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Drug Eruptions | Japan | 15 Mar 1994 | |
| Eczema | Japan | 15 Mar 1994 | |
| Rhinitis, Allergic | Japan | 15 Mar 1994 | |
| Urticaria | Japan | 15 Mar 1994 |





